Evolva

Evolva is a biotechnology company that discovers and develops nutrition ingredients for pharmaceuticals and personal care products. Read more

Oliver Walker's photo - CEO of Evolva

CEO

Oliver Walker

CEO Approval Rating

46/100

Founded:

2004

Status:

PublicIndependent CompanySIX Swiss ExchangeEVE

EVOLVA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

GlycosBio is seen as one of Evolva's biggest rivals. GlycosBio is headquartered in Houston, Texas, and was founded in 2007. Like Evolva, GlycosBio also works within the Biotechnology sector. GlycosBio generates 35% the revenue of Evolva.

Amyris is seen as one of Evolva's top competitors. Amyris was founded in 2003, and its headquarters is in Emeryville, California. Amyris operates in the Biotechnology industry. Amyris has 525 more employees than Evolva.

Robertet is one of Evolva's top rivals. Robertet is a Public company that was founded in Grasse, Other in 1850. Robertet is in the Specialty Chemicals industry. Robertet has 1,730 more employees vs. Evolva.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is IFF a competitor of Evolva?

Evolva Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$8.5M

Evolva's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 10.1B. Over the last three quarters, Evolva's revenue has decreased by 0%. Specifically, in Q4 2020's revenue was $8.5M; in Q3 2020, it was $8.5M; in Q2 2020, it was $8.5M.

Evolva Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Allylix Inc.

Nov 2014

Source »
$46M
Allylix develops terpene products for the fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.

These are all the companies that Evolva has acquired. Evolva's latest acquisition was Allylix Inc. in Nov 2014. Allylix develops terpene products for the fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.

Evolva Funding History

Since Evolva was founded in 2004, it has participated in 1 round of funding. In total Evolva has raised $13.3M. Evolva's funding round was on Dec 2020 for a total of $13.3M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Convertible Note
Dec 2020
$13.3M

Nice & Green

Since Evolva was founded in 2004, it has participated in 1 round of funding. In total Evolva has raised $13.3M. Evolva's funding round was on Dec 2020 for a total of $13.3M

Evolva Investments

No recent investments found related to Evolva

These are all the companies that Evolva has invested in. Evolva's latest investment was Allylix Inc. in Nov 2014. Allylix develops terpene products for the fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.

Evolva News

April 8, 2021MarketScreener

Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2021

(marketscreener.com) EQS Group-Ad-hoc: Evolva Holding SA / Key word: Miscellaneous Evolva shareholder... See more »
March 24, 2021MarketScreener

Evolva announces new Chief Financial Officer

(marketscreener.com) EQS Group-Ad-hoc: Evolva Holding SA / Key word: Miscellaneous Evolva announces n... See more »
March 16, 2021MarketScreener

publishes agenda for 2021 Annual General Meeting

(marketscreener.com) EQS Group-Ad-hoc: Evolva Holding SA / Key word: Miscellaneous Evolva publishes a... See more »
March 3, 2021FinanzNachrichten

Evolva - Addressing the bottlenecks

Evolva's order intake in FY20 was over CHF10m for the first time, with market share gains across busi... See more »
February 26, 2021Nutrition Insight

Glanbia and Evolva release 2020 financial reports, Taiyo's guar gum supplement may aid fertility

26 Feb 2021 --- In nutrition news this week, Glanbia's performance nutrition unit revealed a decline ... See more »
February 25, 2021MarketScreener

reports Full Year Results for 2020, with significant increase in customer demand for Health Ingredients and product expansion

(marketscreener.com) EQS Group-Ad-hoc: Evolva Holding SA / Key word: Annual Results Evolva reports Fu... See more »
January 21, 2021FoodNavigator

Evolva's new ingredient obstructs the body's ability to digest sucrose

Swiss biotech company Evolva is launching a natural sugar blocker for food and drink applications. L-... See more »

Evolva Press Releases

December 4, 2016NewsMaker

Stevia Market Key Players analysis - Purecircle, Ingredion Inc., Tate & Lyle Plc., Evolva, Stevia Corp, Cargill Inc., GLG Life Tech Corp, Stevia Biotech Pvt. Ltd, Steviafirst and X

Market research future published a half cooked research report on Stevia market contains the informat... See more »
September 13, 2016NewsMaker

Stevia Extract Industry Growth, Shares, Opportunities and Forecast to 2021

The Stevia Extract Market research report is a professional and in-depth study on the current state o... See more »
September 5, 2016openPR

Naturex, Merisant Worldwide, Fraken Biochem, Evolva, Danisco, Merisant Worldwide

A market study based on the "Non Sugar Sweetener Market" across the globe, recently added to the repo... See more »
April 22, 2016Business Wire

Cargill, Evolva Holding, Ingredion - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Stevia / Stevia Reba... See more »
November 18, 2015BUSINESS WIRE

Evolva Reaches Second Milestone in Collaboration to Develop Next-Generation, Sustainably Produced Cosmetic Ingredients with L'Oréal

REINACH, Switzerland--(BUSINESS WIRE)--Evolva (SIX:EVE) reaches the second milestone in its R&D colla... See more »
November 2, 2015BUSINESS WIRE

Evolva successfully completes Roquette collaboration, triggering a fourth milestone payment

REINACH, Switzerland--(BUSINESS WIRE)--Evolva (SIX: EVE) today announces the successful completion of... See more »
September 16, 2015NEWSWIRE

Global Industry Analysis and Forecast Till 2025 by Future Market Insights

Vanillin is primarily used in the food and beverages industry to enhance the sweetness of food items ... See more »

Social Media

Evolva Headquarters

Duggingerstrasse 23

Reinach, Basel-CountryCH-4153

41-61-485-2000

Driving Directions »

Trending Companies

Evolva Summary

ABOUT

Overview

Evolva is a biotechnology company that discovers and develops nutrition ingredients for pharmaceuticals and personal care products. Evolva was founded in 2004. Evolva's headquarters is located in Reinach, Basel-Country, CH CH-4153. It has raised 13.3M...

CEO

Evolva's CEO, Oliver Walker, currently has an approval rating of 46%. Evolva's primary competitors are GlycosBio, Amyris & Robertet.

Website

evolva.com

Frequently Asked Questions about Evolva

  1. When was Evolva founded?

    Evolva was founded in 2004
  2. Who is Evolva's CEO?

    Evolva's CEO is Oliver Walker
  3. How much revenue does Evolva generate?

    Evolva generates $8.5M in revenue
  4. How much funding does Evolva have?

    Evolva has historically raised $13.3M in funding
  1. Where is Evolva's headquarters?

    Evolva's headquarters is in Reinach Basel-Country, CH
  2. How many employees does Evolva have?

    Evolva has 70 employees
  3. What sector does Evolva operate in?

    Evolva is in Biotechnology
  4. Who are Evolva's competitors?

    Evolva's top competitors are GlycosBio, Amyris, Robertet